HOME >> MEDICINE >> NEWS
New understanding of a key control mechanism in the brain

REHOVOT, Israel -- January 12, 2000 -- Despite more than a century of research on inhibitory neurons, very little is known on how this small population (10-20% of brain neurons) exerts its controlling effect on the brain. Pivotal for normal brain development, learning, and memory, it is not surprising that inhibitory neurons are involved in most neurological disorders. A recent study at the Weizmann Institute of Science, published in the January 2000 issue of Science, reveals key principles underlying the design and function of this inhibitory system.

By repressing the level of activity in neighboring neurons, inhibitory neurons (I-neurons) prevent the brain from quickly spinning out of control into hyper-excited states or full-blown epilepsy. One of the problems that children with autism and attention deficit hyperactivity disorders (ADHD) have is I-neuron malfunction: their inhibitory system does not effectively suppress unwanted information, impeding their ability to make choices. I-neuron malfunction is involved in memory disorders (such as Alzheimer's disease), neural trauma, and addictions. It also plays a role in a wide range of psychiatric disorders, such as depression, obsessive compulsive disorders, and schizophrenia.

In the past, researchers basically thought that I-neurons just sprayed an inhibitory neurotransmitter called GABA onto their neighbors. But this did not explain how they inhibited the right neurons at exactly the right time and to the right degree. The new study carried out in the laboratory of Prof. Henry Markram of the Weizmann Institute's Neurobiology Department shows how they achieve this.

Controlling the neuron crowd

The research team found new types of I-neurons, revealing that this tiny population is several times more diverse than previously thought. Further, using new methods that they developed, the researchers succeeded in recording directly how individual inhibitory neurons control their neighbors. T
'"/>

Contact: Jeffrey J. Sussman, Asst. V.P. Communications
jeffrey@acwis.org
212-895-7951
American Committee for the Weizmann Institute of Science
12-Jan-2000


Page: 1 2 3

Related medicine news :

1. Monkey pay-per-view study could aid understanding of autism
2. Another step towards understanding the causes of narcolepsy
3. Student nurses need better understanding of poverty-stricken patients
4. Signaling pathway may be key to understanding roots of hypertension
5. Advances in understanding brain circuits responsible for tics in Tourettes shed light on disorder
6. New understanding of neural circuits may help development of thought-controlled prosthetic devices
7. Researchers develop better understanding of tamoxifen resistance in breast cancer patients
8. New study highlights misunderstanding surrounding risks and benefits of tamoxifen
9. Study expands understanding of alcoholic memory disorder
10. Research breakthrough in understanding treatment resistant depression
11. New study provides molecular-level understanding of common anti-malarial drugs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New understanding key control mechanism the brain

(Date:11/22/2014)... Dallas, TX (PRWEB) November 22, 2014 ... Society (ICS) as the complaint that the individual ... times for voiding. The report “Nocturia – Pipeline ... therapeutic development for Nocturia, complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ...
(Date:11/22/2014)... York, New York (PRWEB) November 22, 2014 ... of power morcellators ( http://www.morcellatorlawsuit2015.com ) in minimally-invasive ... 450 new signatures since the end of October, Bernstein ... had signed the petition as of November 21st, 2014. ... 31st, when 86,042 supporters had signed on to the ...
(Date:11/22/2014)... wide variety and complexity of foods served at holiday ... allergies, an expert warns. "Every person is different ... that it can be really difficult to avoid all ... allergy and clinical immunology at Wake Forest Baptist Medical ... you know you have food allergies, caution should overrule ...
(Date:11/22/2014)... York, New York (PRWEB) November 22, 2014 ... filed on behalf of patients who allegedly developed Type ... forward in the federal multidistrict litigation now underway in ... LLP reports. According to court documents, the litigation will ... 10:00 a.m. The Court has directed Lead Counsel for ...
(Date:11/22/2014)... Hastings and Hastings, a discount accident attorney in ... with the option of leaving an online review using ... and easy to navigate website that has recently been ... allows clients to research the Hastings and Hastings law ... when retaining an attorney. Those who have been injured ...
Breaking Medicine News(10 mins):Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3
(Date:11/21/2014)... Nov. 21, 2014 Clementia ... Medicines Agency (EMA) has granted Orphan Medicinal ... product candidate, for the treatment of fibrodysplasia ... severely disabling genetic disease characterized by painful, ... and new abnormal bone formation. This process, ...
(Date:11/21/2014)... IRVINE, Calif. , Nov. 20, 2014  Edwards ... leader in the science of heart valves and hemodynamic ... corporate giving in 2014 to support a strong launch ... Heartbeat Matters , and to improve the global communities ... In 2014, Edwards, global corporate giving will exceed $8 ...
(Date:11/21/2014)... /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ) announced today ... be presenting at the 26 th Annual Piper Jaffray ... New York . The formal presentation is scheduled ... addition, Mr. Krakauer and Jorgen B. Hansen , President ... the day. An audio webcast will be ...
Breaking Medicine Technology:Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2
Cached News: